肠道微生物群和营养学在乳糜泻中的作用的系统回顾和荟萃分析:最新进展

Giovana Sales Longhini, Layra Rayanne de Oliveira Ferraz Santos, Luca Campassi Bonini, Luiza Braile Verdi, Marcela Vayego Lourenço, Thiago Salomão Munhoz, V. Favaretto, I. J. Zotarelli-Filho, J. Vidanapathirana, Manudi Vidanapathirana, Durval Ribas Filho
{"title":"肠道微生物群和营养学在乳糜泻中的作用的系统回顾和荟萃分析:最新进展","authors":"Giovana Sales Longhini, Layra Rayanne de Oliveira Ferraz Santos, Luca Campassi Bonini, Luiza Braile Verdi, Marcela Vayego Lourenço, Thiago Salomão Munhoz, V. Favaretto, I. J. Zotarelli-Filho, J. Vidanapathirana, Manudi Vidanapathirana, Durval Ribas Filho","doi":"10.54448/ijn22107","DOIUrl":null,"url":null,"abstract":"Introduction: Celiac disease (CD) is one of the most common disorders related to diet, with a global prevalence of about 1%. The aggravations caused by CD promote an imbalance in the gut microbiota (GM). However, it is not yet known specifically how the gut microbiota plays a role in the pathogeny of this disease, and whether microbiota dysbiosis would be the cause or consequence of CD. Objective: The present study aimed to correlate the main results of the action of the gut microbiota and functional nutrition for the treatment of celiac disease. Methods: This study followed the rules of PRISMA. The research was carried out from June 2021 to 2022 and developed at Scopus, PubMed/Medline, Science Direct, Google Scholar, and Ovid. The quality of the evidence was classified according to the GRADE. The Cochrane instrument was adopted to assess the risk of bias of included studies. For data analysis, Minitab 18® statistical program was used. A common descriptive statistical analysis was performed. The One-Way test (ANOVA) was applied, adopting the α level lower than 0.05 with a statistically significant difference for the 95% CI. Results: The present study found thirteen (13) important clinical studies, of which 12 were Randomized Controlled Studies (RCTs) and one (1) Cross-Sectional Observational study of the total of 113 studies evaluated, showing a high quality of scientific evidence in the studies addressed, with a level of scientific evidence AI. Also, the analyzed studies showed high homogeneity in the results (high association=>50%) to studies with larger sample sizes (greater precision), presenting 98.65%. The present study showed that certain diets/probiotics can promote the improvement of GM as well as DC, especially in patients on a gluten-free diet (GFD). Therefore, patients who follow a GFD may be prone to nutritional deficiencies. Conclusion: According to the results, although some studies have a small sample size, the main randomized clinical studies showed that the modulation of nutrients/probiotics and the gut microbiota improve the inflammatory process of celiac disease, especially in patients with a gluten-free diet.","PeriodicalId":137919,"journal":{"name":"International Journal of Nutrology","volume":" 17","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematic review and meta-analysis of the action of gut microbiota and nutrology in celiac disease: state of the art\",\"authors\":\"Giovana Sales Longhini, Layra Rayanne de Oliveira Ferraz Santos, Luca Campassi Bonini, Luiza Braile Verdi, Marcela Vayego Lourenço, Thiago Salomão Munhoz, V. Favaretto, I. J. Zotarelli-Filho, J. Vidanapathirana, Manudi Vidanapathirana, Durval Ribas Filho\",\"doi\":\"10.54448/ijn22107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Celiac disease (CD) is one of the most common disorders related to diet, with a global prevalence of about 1%. The aggravations caused by CD promote an imbalance in the gut microbiota (GM). However, it is not yet known specifically how the gut microbiota plays a role in the pathogeny of this disease, and whether microbiota dysbiosis would be the cause or consequence of CD. Objective: The present study aimed to correlate the main results of the action of the gut microbiota and functional nutrition for the treatment of celiac disease. Methods: This study followed the rules of PRISMA. The research was carried out from June 2021 to 2022 and developed at Scopus, PubMed/Medline, Science Direct, Google Scholar, and Ovid. The quality of the evidence was classified according to the GRADE. The Cochrane instrument was adopted to assess the risk of bias of included studies. For data analysis, Minitab 18® statistical program was used. A common descriptive statistical analysis was performed. The One-Way test (ANOVA) was applied, adopting the α level lower than 0.05 with a statistically significant difference for the 95% CI. Results: The present study found thirteen (13) important clinical studies, of which 12 were Randomized Controlled Studies (RCTs) and one (1) Cross-Sectional Observational study of the total of 113 studies evaluated, showing a high quality of scientific evidence in the studies addressed, with a level of scientific evidence AI. Also, the analyzed studies showed high homogeneity in the results (high association=>50%) to studies with larger sample sizes (greater precision), presenting 98.65%. The present study showed that certain diets/probiotics can promote the improvement of GM as well as DC, especially in patients on a gluten-free diet (GFD). Therefore, patients who follow a GFD may be prone to nutritional deficiencies. Conclusion: According to the results, although some studies have a small sample size, the main randomized clinical studies showed that the modulation of nutrients/probiotics and the gut microbiota improve the inflammatory process of celiac disease, especially in patients with a gluten-free diet.\",\"PeriodicalId\":137919,\"journal\":{\"name\":\"International Journal of Nutrology\",\"volume\":\" 17\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Nutrology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54448/ijn22107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nutrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54448/ijn22107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

乳糜泻(CD)是最常见的与饮食有关的疾病之一,全球患病率约为1%。乳糜泻引起的恶化促进了肠道微生物群(GM)的不平衡。然而,肠道菌群如何在乳糜泻的发病过程中发挥作用,以及菌群失调是乳糜泻的病因还是后果,目前尚不清楚。目的:本研究旨在将肠道菌群作用的主要结果与功能性营养治疗乳糜泻的结果联系起来。方法:本研究遵循PRISMA规则。该研究于2021年6月至2022年进行,由Scopus、PubMed/Medline、Science Direct、Google Scholar和Ovid开发。根据GRADE对证据的质量进行分类。采用Cochrane工具评估纳入研究的偏倚风险。数据分析使用Minitab 18®统计程序。进行常见的描述性统计分析。采用单因素检验(ANOVA),采用α水平< 0.05,95% CI差异有统计学意义。结果:本研究共纳入13项重要临床研究,其中12项为随机对照研究(RCTs), 1项为横断面观察性研究(横断面观察性研究),共纳入113项研究,研究结果显示科学证据质量较高,科学证据AI水平较高。此外,所分析的研究结果与样本量较大(精度较高)的研究结果具有较高的同质性(高相关性=>50%),为98.65%。目前的研究表明,某些饮食/益生菌可以促进GM和DC的改善,特别是在无麸质饮食(GFD)的患者中。因此,遵循GFD的患者可能容易出现营养缺乏。结论:根据结果,尽管一些研究的样本量较小,但主要的随机临床研究表明,营养/益生菌和肠道微生物群的调节可以改善乳糜泻的炎症过程,特别是在无麸质饮食的患者中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Systematic review and meta-analysis of the action of gut microbiota and nutrology in celiac disease: state of the art
Introduction: Celiac disease (CD) is one of the most common disorders related to diet, with a global prevalence of about 1%. The aggravations caused by CD promote an imbalance in the gut microbiota (GM). However, it is not yet known specifically how the gut microbiota plays a role in the pathogeny of this disease, and whether microbiota dysbiosis would be the cause or consequence of CD. Objective: The present study aimed to correlate the main results of the action of the gut microbiota and functional nutrition for the treatment of celiac disease. Methods: This study followed the rules of PRISMA. The research was carried out from June 2021 to 2022 and developed at Scopus, PubMed/Medline, Science Direct, Google Scholar, and Ovid. The quality of the evidence was classified according to the GRADE. The Cochrane instrument was adopted to assess the risk of bias of included studies. For data analysis, Minitab 18® statistical program was used. A common descriptive statistical analysis was performed. The One-Way test (ANOVA) was applied, adopting the α level lower than 0.05 with a statistically significant difference for the 95% CI. Results: The present study found thirteen (13) important clinical studies, of which 12 were Randomized Controlled Studies (RCTs) and one (1) Cross-Sectional Observational study of the total of 113 studies evaluated, showing a high quality of scientific evidence in the studies addressed, with a level of scientific evidence AI. Also, the analyzed studies showed high homogeneity in the results (high association=>50%) to studies with larger sample sizes (greater precision), presenting 98.65%. The present study showed that certain diets/probiotics can promote the improvement of GM as well as DC, especially in patients on a gluten-free diet (GFD). Therefore, patients who follow a GFD may be prone to nutritional deficiencies. Conclusion: According to the results, although some studies have a small sample size, the main randomized clinical studies showed that the modulation of nutrients/probiotics and the gut microbiota improve the inflammatory process of celiac disease, especially in patients with a gluten-free diet.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信